IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,412,785 | -8.7% | 458,236 | +0.9% | 0.01% | 0.0% |
| Q2 2023 | $4,833,762 | +110411.2% | 454,301 | +9.3% | 0.01% | 0.0% |
| Q1 2023 | $4,374 | -11.8% | 415,825 | +3.9% | 0.01% | -28.6% |
| Q4 2022 | $4,957 | -99.9% | 400,059 | +2.6% | 0.01% | +16.7% |
| Q3 2022 | $4,039,000 | +12.5% | 389,840 | +25.2% | 0.01% | +20.0% |
| Q2 2022 | $3,591,000 | +73.4% | 311,444 | +89.2% | 0.01% | +66.7% |
| Q1 2022 | $2,071,000 | +12.2% | 164,608 | +4.0% | 0.00% | +50.0% |
| Q4 2021 | $1,846,000 | -25.6% | 158,331 | -16.6% | 0.00% | -33.3% |
| Q3 2021 | $2,480,000 | +4.9% | 189,862 | +3.4% | 0.00% | 0.0% |
| Q2 2021 | $2,364,000 | +10.2% | 183,689 | -4.3% | 0.00% | 0.0% |
| Q1 2021 | $2,146,000 | -6.9% | 191,987 | -5.1% | 0.00% | 0.0% |
| Q4 2020 | $2,305,000 | +18.3% | 202,405 | -6.6% | 0.00% | 0.0% |
| Q3 2020 | $1,949,000 | -32.5% | 216,685 | -22.5% | 0.00% | -40.0% |
| Q2 2020 | $2,887,000 | +19.6% | 279,770 | +17.0% | 0.01% | 0.0% |
| Q1 2020 | $2,413,000 | -17.5% | 239,179 | +8.8% | 0.01% | 0.0% |
| Q4 2019 | $2,925,000 | +58.8% | 219,762 | +2.4% | 0.01% | +66.7% |
| Q3 2019 | $1,842,000 | -17.8% | 214,567 | +4.7% | 0.00% | -25.0% |
| Q2 2019 | $2,242,000 | -10.2% | 204,952 | +11.0% | 0.00% | -20.0% |
| Q1 2019 | $2,498,000 | +29.4% | 184,590 | -0.9% | 0.01% | +25.0% |
| Q4 2018 | $1,930,000 | -16.3% | 186,301 | +49.1% | 0.00% | 0.0% |
| Q3 2018 | $2,307,000 | -9.9% | 124,957 | -6.7% | 0.00% | -20.0% |
| Q2 2018 | $2,560,000 | +29.9% | 133,892 | +4.9% | 0.01% | +25.0% |
| Q1 2018 | $1,970,000 | +0.7% | 127,657 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $1,956,000 | -20.3% | 130,477 | -16.2% | 0.00% | -20.0% |
| Q3 2017 | $2,455,000 | -15.7% | 155,675 | +1.0% | 0.01% | -28.6% |
| Q2 2017 | $2,911,000 | +13.4% | 154,173 | +2.5% | 0.01% | +16.7% |
| Q1 2017 | $2,567,000 | +16.7% | 150,461 | +4.6% | 0.01% | 0.0% |
| Q4 2016 | $2,199,000 | +1.4% | 143,825 | +5.3% | 0.01% | 0.0% |
| Q3 2016 | $2,169,000 | +24.0% | 136,604 | +2.1% | 0.01% | +20.0% |
| Q2 2016 | $1,749,000 | +26.9% | 133,766 | +6.2% | 0.01% | +25.0% |
| Q1 2016 | $1,378,000 | -3.9% | 125,920 | +1.8% | 0.00% | -20.0% |
| Q4 2015 | $1,434,000 | +24.2% | 123,715 | +11.6% | 0.01% | +25.0% |
| Q3 2015 | $1,155,000 | -11.6% | 110,875 | +2.3% | 0.00% | 0.0% |
| Q2 2015 | $1,307,000 | -28.4% | 108,348 | -5.1% | 0.00% | -20.0% |
| Q1 2015 | $1,826,000 | +27.2% | 114,133 | +21.9% | 0.01% | +25.0% |
| Q4 2014 | $1,435,000 | +13.5% | 93,648 | -4.0% | 0.00% | 0.0% |
| Q3 2014 | $1,264,000 | -15.8% | 97,542 | -0.4% | 0.00% | 0.0% |
| Q2 2014 | $1,502,000 | +49.9% | 97,977 | +20.5% | 0.00% | +33.3% |
| Q1 2014 | $1,002,000 | +6.0% | 81,328 | -0.1% | 0.00% | 0.0% |
| Q4 2013 | $945,000 | -2.7% | 81,428 | -0.6% | 0.00% | 0.0% |
| Q3 2013 | $971,000 | +18.1% | 81,928 | -0.9% | 0.00% | 0.0% |
| Q2 2013 | $822,000 | – | 82,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |